Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
NCT ID: NCT05818644
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
400 participants
OBSERVATIONAL
2023-09-28
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Research question:
* What are the overall incidence of HAC and the effectiveness of all treatment strategies for HAC after pediatric LT?
* What are the current management practices in the experience of centers, anticoagulant therapy, screening protocol, and assessment criteria for HAC after pediatric LT?
The burden of participation is considered to be minimal, and limited to the questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complications of Pediatric Liver Transplantation
NCT04104971
Prevalence, Risk Factors and Outcomes of Pediatric Vascular Thrombosis
NCT05889897
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
NCT00374335
Retrospective Review of CT and MR in Pediatric Patients With Cholestasis
NCT01252043
Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children
NCT06117488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conservative treatment
No interventions assigned to this group
Surgical revascularization
No interventions assigned to this group
Endovascular revascularization
No interventions assigned to this group
Re-transplantation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The age of the patient is below 18 years at the time of diagnosis and intervention
* The date of diagnosis of HAC or intervention was before January 1st 2023. HAC occurring after first or subsequent LTs are included.
Exclusion Criteria
0 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
J. P. Garrahan Hospital
UNKNOWN
Hospital Italiano de Buenos Aires
OTHER
Royal Children's Hospital
OTHER
Medical University of Innsbruck
UNKNOWN
Hospital Sírio-Libanês
UNKNOWN
Hospital Santo Antonio
UNKNOWN
Faculty of Medicine & Dentistry, University of Alberta
UNKNOWN
Zhejiang University
OTHER
Thomayer University Hospital
OTHER
Hôpital Bicêtre
UNKNOWN
University Children's Hospital
OTHER
Hannover Medical School
OTHER
Universitätsklinikum Hamburg-Eppendorf
OTHER
Dr Rela Institute and Medical Centre
UNKNOWN
Amrita Institute of Medical Sciences & Research Centre
UNKNOWN
Max Super Speciality Hospital
OTHER
Aster CMI Hospital
UNKNOWN
ASST Papa Giovanni XXIII Hospital
UNKNOWN
Bambino Gesù Children's Hospital
UNKNOWN
National Centre for Child Health and Development
UNKNOWN
Auckland City Hospital
OTHER_GOV
Children's Memorial Health Institute
UNKNOWN
King Faisal Specialist Hospital & Research Center
OTHER
National University Hospital, Singapore
OTHER
Wits Donald Gordon Medical Centre
UNKNOWN
La Paz University Hospital
UNKNOWN
Vall d'Hebron Barcelona Hospital Campus
UNKNOWN
Karolinska Institutet
OTHER
University Hospital, Geneva
OTHER
Birmingham Women's and Children's Hospital
UNKNOWN
Primary Children's Hospital
OTHER
Children's Hospital of Philadelphia
OTHER
Children's Hospital Pittsburgh
UNKNOWN
Recanati-Miller Transplantation Institute, Mount Sinai Hospital
UNKNOWN
Ann and Robert H. Lurie Children's Hospital of Chicago
UNKNOWN
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Groningen
Groningen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Li W, van der Doef HPJ, Wildhaber BE, Marra P, Bravi M, Pinelli D, Minetto J, Dip M, Sierre S, de Santibanes M, Ardiles V, Uno JW, Hardikar W, Bates S, Goh L, Aldrian D, Seisenbacher J, Vogel GF, Neto JS, Antunes da Fonseca E, Magalhaes Costa C, Ferreira CT, Nader LS, Farina MA, Dajani KZ, Parente A, Bigam DL, Liang TB, Bai X, Zhang W, Gonsorcikova L, Fronek J, Bohus S, Franchi-Abella S, Gonzales E, Guerin F, Junge N, Baumann U, Richter N, Hartleif S, Sturm E, Rajakannu M, Palaniappan K, Rela M, Pawaria A, Rajakrishnan H, Surendran S, Kumar M, Agarwal S, Gupta S, Asthana S, Bandewar V, Raichurkar K, Spada M, Monti L, Alterio T, Yanagi Y, Uchida H, Komine R, Evans H, Carr-Boyd P, Duncan D, Stefanowicz M, Latka-Grot J, Kolesnik A, Broering DC, Raptis DA, Ann H Marquez K, Mali V, Aw M, Beretta M, Van der Schyff F, Quintero-Bernabeu J, Mercadal-Hally M, Larrarte K M, Andres AM, Hernandez-Oliveros F, Frauca E, Casswall T, Jorns C, Delle M, Gupte G, Sharif K, McGuirk S, Superina R, Caicedo JC, Jaramillo C, Bitterfeld L, Kastenberg Z, Shah AA, Domenick B, Acord MR, Mazariegos GV, Soltys K, DiNorcia J, Antala S, Florman SS, Buchholz BM, Herden U, Fischer L, Dierckx RAJO, Hartog H, Bokkers RPH. Incidence, management and outcomes in hepatic artery complications after paediatric liver transplantation: protocol of the retrospective, international, multicentre HEPATIC Registry. BMJ Open. 2024 Jun 12;14(6):e081933. doi: 10.1136/bmjopen-2023-081933.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.